Josh Chen
Impact in
-
- Mosquito-borne diseases and control
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Statistical Methods in Clinical Trials 12
- Advanced Causal Inference Techniques 1
-
- Clostridium difficile and Clostridium perfringens research 1
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Gang Li (5 shared papers)Ming Zhu (2 shared papers)Hui Quan (5 shared papers)Ayman Chit (1 shared paper)Yoko Tanaka (4 shared papers)Rosalind C. Hollingsworth (1 shared paper)Michael Greenberg (1 shared paper)Saranya Sridhar (1 shared paper)
- Journals
- Contemporary Clinical Trials (3 papers)Statistics in Biopharmaceutical Research (2 papers)Journal of Biopharmaceutical Statistics (2 papers)Therapeutic Innovation & Regulatory Science (2 papers)Statistics in Medicine (1 paper)
- Partner nations
- United StatesFranceJapan
In The Last Decade
Josh Chen
14 papers receiving 735 citations
Josh Chen's Hit Papers
Peers
Comparison fields: 5 of 56
- Public Health, Environmental and Occupational Health 504
- Infectious Diseases 128
- Statistics and Probability 60
- Applied Microbiology and Biotechnology 6
- Immunology 34
Countries citing papers authored by Josh Chen
This map shows the geographic impact of Josh Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josh Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josh Chen more than expected).
Fields of papers citing papers by Josh Chen
This network shows the impact of papers produced by Josh Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josh Chen. The network helps show where Josh Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Josh Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy Hit paper breakdown → | 2018 | 629 |
| 2 | 2020 | 61 | |
| 3 | 2019 | 29 | |
| 4 | 2017 | 11 | |
| 5 | 2012 | 7 | |
| 6 | 2021 | 5 | |
| 7 | 2013 | 4 | |
| 8 | 2021 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2019 | 2 | |
| 11 | 2020 | 2 | |
| 12 | 2008 | 1 | |
| 13 | 2018 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2025 | 0 |
About Josh Chen
Josh Chen is a scholar working on Statistics and Probability, Infectious Diseases, Pediatrics, Perinatology and Child Health, Economics and Econometrics and Public Health, Environmental and Occupational Health, having authored 15 papers that have together received 760 indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (12 papers), Clostridium difficile and Clostridium perfringens research (1 paper), Pharmaceutical Economics and Policy (1 paper), Advanced Causal Inference Techniques (1 paper), Silicon and Solar Cell Technologies (1 paper), Mosquito-borne diseases and control (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Pharmaceutical studies and practices (1 paper). The work is most often cited by research in Public Health, Environmental and Occupational Health (504 citations), Infectious Diseases (128 citations), Statistics and Probability (60 citations), Applied Microbiology and Biotechnology (6 citations) and Immunology (34 citations). Josh Chen has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Gang Li, Ming Zhu, Hui Quan, Ayman Chit, Yoko Tanaka, Rosalind C. Hollingsworth, Michael Greenberg, Saranya Sridhar, Sanjay Gurunathan and Yining Wang. Their work appears in journals such as Contemporary Clinical Trials, Statistics in Biopharmaceutical Research, Journal of Biopharmaceutical Statistics, Therapeutic Innovation & Regulatory Science and Statistics in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.